摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(1,3-Dioxobenzo[de]isoquinolin-2-yl)methyl]benzenesulfonamide | 1429784-85-9

中文名称
——
中文别名
——
英文名称
4-[(1,3-Dioxobenzo[de]isoquinolin-2-yl)methyl]benzenesulfonamide
英文别名
4-[(1,3-dioxobenzo[de]isoquinolin-2-yl)methyl]benzenesulfonamide
4-[(1,3-Dioxobenzo[de]isoquinolin-2-yl)methyl]benzenesulfonamide化学式
CAS
1429784-85-9
化学式
C19H14N2O4S
mdl
——
分子量
366.397
InChiKey
CNFAHVNPEUHGNP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    106
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    磺胺米隆1,8-萘二甲酸酐sodium acetate溶剂黄146 作用下, 反应 12.0h, 以91%的产率得到4-[(1,3-Dioxobenzo[de]isoquinolin-2-yl)methyl]benzenesulfonamide
    参考文献:
    名称:
    含N-苯磺酰胺基团的多环酰亚胺的合成及其碳酸酐酶抑制作用
    摘要:
    通过使苯磺酰胺与适当的多环酸酐在回流的冰醋酸中反应来制备一系列多环酰亚胺。合成的单磺酰胺和双磺酰胺被评估为碳酸酐酶抑制剂(CA,EC 4.2.1.1),更准确地针对人(h)亚型hCA I,II,IX和XII,其中一些涉及多种病理如青光眼,癫痫和癌症。检测了几种低纳摩尔浓度和同工型选择性的hCA II,IX和XII抑制剂,并详细讨论了用此类化合物抑制CA的构效关系。计算研究使我们能够解释其中某些酶抑制剂的功效和同工型选择性行为。
    DOI:
    10.1016/j.bmc.2017.07.056
点击查看最新优质反应信息

文献信息

  • Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2
    作者:Ibrahim A. Al-Suwaidan、Amer M. Alanazi、Adel S. El-Azab、Abdulrahman M. Al-Obaid、Kamal E.H. ElTahir、Azza R. Maarouf、Mohamed A. Abu El-Enin、Alaa A.-M. Abdel-Aziz
    DOI:10.1016/j.bmcl.2013.02.107
    日期:2013.5
    A group of cyclic imides (1-10) was designed for evaluation as a selective COX-2 inhibitors and investigated in vivo for their anti-inflammatory activity. Compounds 6a, 6b, 8a, 8b, 9a, 9b, 10a and 10b were proved to be potent COX-2 inhibitors with IC50 range of 0.1-4.0 mu M. In vitro COX-1/COX-2 inhibition structure-activity studies identified compound 8a as a highly potent (IC50 = 0.1 mu M), and an extremely selective [COX-2 (SI) > 1000] comparable to celecoxib [COX-2 (SI) > 384], COX-2 inhibitor that showed superior anti-inflammatory activity (ED50 = 72.4 mg/kg) relative to diclofenac (ED50 = 114 mg/kg). Molecular modeling was carried out through docking the designed compounds into the COX-2 binding site to predict if these compounds have analogous binding mode to the COX-2 inhibitors. The study showed that the homosulfonamide fragment of 8a inserted deep inside the 2 degrees-pocket of the COX-2 active site, where the SO2NH2 group underwent H-bonding interaction with Gln(192)(2.95 angstrom), Phe(518)(2.82 angstrom) and Arg(513)(2.63 and 2.73 angstrom). Docking study of the synthesized compound 8a into the active site of COX-2 revealed a similar binding mode to SC-558, a selective COX-2 inhibitor. (C) 2013 Elsevier Ltd. All rights reserved.
  • Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties
    作者:Andrea Angeli、Alaa A.-M. Abdel-Aziz、Alessio Nocentini、Adel S. El-Azab、Paola Gratteri、Claudiu T. Supuran
    DOI:10.1016/j.bmc.2017.07.056
    日期:2017.10
    A series of polycyclic imides was prepared by reaction of the benzenesulfonamide with an appropriate polycyclic acid anhydride in refluxing glacial acetic acid. The synthesized mono- and bis-sulfonamides were evaluated as a carbonic anhydrase inhibitors (CA, EC 4.2.1.1), more precisely against the human (h) isoforms hCA I, II, IX and XII, some of which are involved in various pathologies, such as glaucoma
    通过使苯磺酰胺与适当的多环酸酐在回流的冰醋酸中反应来制备一系列多环酰亚胺。合成的单磺酰胺和双磺酰胺被评估为碳酸酐酶抑制剂(CA,EC 4.2.1.1),更准确地针对人(h)亚型hCA I,II,IX和XII,其中一些涉及多种病理如青光眼,癫痫和癌症。检测了几种低纳摩尔浓度和同工型选择性的hCA II,IX和XII抑制剂,并详细讨论了用此类化合物抑制CA的构效关系。计算研究使我们能够解释其中某些酶抑制剂的功效和同工型选择性行为。
查看更多